Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


Point of Care Systems for Biosurveillance

17 Jun 2013 - 17 Jun 2013 - Alexandria, VA, USA



Bookmark and Share


The National Strategy for Biosurveillance, 2013, is formulated around four core functions: 1) Scan and discern the environment; 2) Identify and integrate essential information; 3) Alert and inform decision makers; and 4) Forecast and advise Impacts.  This workshop will focus on the second core function – Identify and Integrate Essential Information.  This function is focused to expedite incident detection and assessment.  “Although all incidents have unique aspects, there are common elements of any national public health emergency.  As with a health care provider and a new patient, there are certain key questions asked to identify symptoms and narrow probable causes to assist with patient treatment.”  In order to fulfill this requirement the community must improve diagnostic capability, especially at point-of-care to enable accurate and timely collection of information for early detection and throughout an incident or outbreak.

A point-of-care (POC) system is a hospital or outpatient information system that includes bedside terminals, instrumentation, sensors, or other devices for capturing and entering data at the location where the patients receive their care.  Doctors and clinicians use POC systems to record directly the details of patient encounters, to review medical information, and to order tests, referrals, prescriptions, and other services related to the patient’s ailments.  Modern POC systems are being designed to replace many of the functions previously associated with paper documents.

POC systems are part of the future of biosurveillance.  A POC system facilitates the electronic capture of key diagnostic data that is directly or readily translated to computer-interpretable form.  POC systems typically include decision support tools like drug interactions and to even suggest diagnoses.  Ideally doctors and clinicians will have sensors that use naturally bodily fluids for initial diagnosis and then the information is transmitted directly into the POC system where further analysis is conducted and feedback provided to doctor or clinician in real time.  
 
Topics to be addressed will include:

·         Improve point of care (POC) diagnostics capabilities

·         Accurate and real time collection for physicians and clinicians

·         POC decision support capabilities – i.e. diagnoses and drug interactions

·         POC DNA sequencing

·         Link POC results to public health databases and near real time feedback mechanisms

·         Data standards for interoperability of POC system, the electronic health record, and biosurveillance-related databases

·         Data analysis and modeling supporting POC-generated data – i.e. determining relationship between the completeness of sampling of a population and the size of outbreaks of diseases that can be detected



Further information
Scientific News
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Gene Analysis System Could Accelerate Pace of Research on the Space Station
The WetLab-2 system will enable spaceflight genomic studies involving a wide variety of biospecimen types in the unique microgravity environment of space.
Liquid Biopsy for NSCLC
'Liquid biopsy' blood test accurately detects key genetic mutations in most common form of lung cancer, study finds.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Seeing Cell to Cell Differences
Seeing differences between individual cells for first time explains symptoms of rare genetic disorders, finds penn study.
Circular RNAs Implicated in Cancer
Circular RNAs – like their protein counterparts – are also affected by genomic rearrangements in cancer, resulting in abnormal fusions.
Know Thy Helicobacter pylori
Non-invasive method for genotyping H.pylori developed.
Zika Test Authorized for Emergency Use
n response to a request from the CDC, the FDA has issued an Emergency Use Authorization (EUA) for a diagnostic tool for Zika virus that will be distributed to qualified laboratories.
Lighting Up Disease-Carrying Mosquitoes
Sandia’s QUASR enables speedy, accurate detection of West Nile and other viruses.
Ultra-Sensitive Test for Cancers, HIV
Test developed that is thousands of times more sensitive than current diagnostics.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!